If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
Zurzuvae enhances the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that sends signals in the brain to calm ...
18hOpinion
The Goopification of Ketamine Therapy
According to Butler, Kuya’s process begins with an assessment by the medical team, led by a physician’s assistant, who goes ...
Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...
1dOpinion
The Spin Doctors at the FDA
Makary and Prasad duck responsibility for killing a melanoma drug.
Citing a ProPublica investigation, lawmakers are calling on the FDA to conduct more drug testing and to alert hospitals and ...
Two Texas compounding pharmacies are the latest to get sued in Eli Lilly’s multi-state battle to stop sales of replica ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA ...
The drug, elinzanetant, is expected to be available in the United States beginning in November under the brand name Lynkuet, ...
Inhibrx Biosciences manages research funds well and could see first approval in 2026, yet market concerns signal caution.
We are gratified the FDA has granted Orphan Drug Designation to daraxonrasib for the treatment of pancreatic cancer, a devastating disease with limited therapeutic options and representing a large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback